Recently, the Ministry of Science and Technology announced the 2022 annual list of projects approved under the National Key R&D Program's special focus on diagnostic equipment and biomedical materials. Novel Medical's "Dual-Head Variable-Angle Human SPECT/CT Development" project has been successfully approved with a funding of 20 million RMB, contributing to national science and technology innovation during the 14th Five-Year Plan.
The project is led by Beijing Novel Medical Equipment Co., Ltd., in collaboration with Tsinghua University, Peking Union Medical College Hospital, Affiliated Hospital of Inner Mongolia Medical University, First Hospital of Shanxi Medical University, Nanfang Hospital of Southern Medical University, Liaoning Inspection and Certification Center, and the Chinese Society of Medical Equipment.
Addressing China's heavy reliance on imported SPECT/CT equipment, the project aims to develop a domestically-produced, digitally-enhanced, variable-angle dual-head SPECT/CT system with independent intellectual property rights. It introduces the innovative use of a high-performance multi-pinhole collimator on traditional SPECT detectors for second-level dynamic imaging, breaking foreign technological monopolies and filling market gaps, thus providing efficient solutions for clinical nuclear medicine detection.
Leveraging Tsinghua University's technological advantages, Novel Medical independently develops three product lines: clinical molecular imaging, preclinical molecular imaging, and nuclear security. In collaboration with multiple institutions, it has established "clinical research bases" and "clinical demonstration centers" undertaking numerous national and provincial projects. This multi-functional comprehensive platform integrates production, academia, research, and application.
Leading the National Key R&D Program project showcases Novel Medical's innovative research and comprehensive strength. Moving forward, the company will continue to innovate in the field of molecular imaging, supporting the establishment of new industrial forms, altering industry competition patterns, and promoting the advancement of China's medical device industry to an international level.
|
Language
